secwatch.observer — SEC 8-K summary
======================================

Issuer:     Onconetix, Inc. (ONCO)
CIK:        0001782107
Form:       8-K
Filed at:   2023-04-24T23:59:59+00:00
Accession:  0001213900-23-031827
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Blue Water Vaccines changes name to Blue Water Biotech after ENTADFI acquisition
--------------------------------------------------------------------------------

- Company changed name from Blue Water Vaccines Inc. to Blue Water Biotech Inc., effective April 21, 2023.
- Acquired ENTADFI (FDA-approved for benign prostatic hyperplasia) from Veru Inc., marking transition to commercial stage.
- Commercial team led by Frank Jaeger to launch ENTADFI; pipeline includes vaccines for pneumococcal, flu, Marburg, Chlamydia.
- Common stock continues trading on Nasdaq under ticker BWV.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782107/000121390023031827/0001213900-23-031827-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782107/000121390023031827/ea177344-8k_bluewater.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-031827

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer